A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
Open Access
- 7 February 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (2), e16284
- https://doi.org/10.1371/journal.pone.0016284
Abstract
The influenza surface glycoprotein neuraminidase (NA) is essential for the efficient spread of the virus. Antiviral drugs such as Tamiflu (oseltamivir) and Relenza (zanamivir) that inhibit NA enzyme activity have been shown to be effective in the treatment of influenza infections. The recent ‘swine flu’ pandemic and world-wide emergence of Tamiflu-resistant seasonal human influenza A(H1N1) H274Y have highlighted the need for the ongoing development of new anti-virals, efficient production of vaccine proteins and novel diagnostic tools. Each of these goals could benefit from the production of large quantities of highly pure and stable NA. This publication describes a generic expression system for NAs in a baculovirus Expression Vector System (BEVS) that is capable of expressing milligram amounts of recombinant NA. To construct NAs with increased stability, the natural influenza NA stalk was replaced by two different artificial tetramerization domains that drive the formation of catalytically active NA homotetramers: GCN4-pLI from yeast or the Tetrabrachion tetramerization domain from Staphylothermus marinus. Both recombinant NAs are secreted as FLAG-tagged proteins to allow for rapid and simple purification. The Tetrabrachion-based NA showed good solubility, increased stability and biochemical properties closer to the original viral NA than the GCN4-pLI based construct. The expressed quantities and high quality of the purified recombinant NA suggest that this expression system is capable of producing recombinant NA for a broad range of applications including high-throughput drug screening, protein crystallisation, or vaccine development.This publication has 57 references indexed in Scilit:
- Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesJournal of Medicinal Chemistry, 2010
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir ResistanceScience, 2010
- Neuraminidase Stalk Length and Additional Glycosylation of the Hemagglutinin Influence the Virulence of Influenza H5N1 Viruses for MiceJournal of Virology, 2009
- Structural Characterization of the 1918 Influenza Virus H1N1 NeuraminidaseJournal of Virology, 2008
- Structure determination of the 1918 H1N1 neuraminidase from a crystal with lattice-translocation defectsActa Crystallographica Section D-Biological Crystallography, 2008
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2Published by Elsevier BV ,2008
- Structure of a designed, right‐handed coiled‐coil tetramer containing all biological amino acidsProtein Science, 2007
- Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their UseAntimicrobial Agents and Chemotherapy, 2006
- Tetrabrachion: A Filamentous Archaebacterial Surface Protein Assembly of Unusual Structure and Extreme StabilityJournal of Molecular Biology, 1995
- Expression of influenza neuraminidase in baculovirus-infected cellsVirus Research, 1992